RSV (Respiratory Syncytial Virus) is a common respiratory virus that usually causes mild, cold-like symptoms. However, it can be dangerous for infants and children with high-risk conditions.
RSV spreads from person to person like a cold virus, through contact with saliva, mucus, or nasal discharge. It is the most common reason for hospitalization in children less than 1 year of age. Symptoms of RSV in babies can vary.
RSV usually causes an upper respiratory infection with fever, cough, and congestion. In some cases, it affects the lower respiratory tract and leads to fast breathing, belly breathing, and wheezing. Symptoms are typically worst 3–5 days into the illness.
According to the CDC, RSV antibody protection can reduce the risk of severe illness by about 80%.
A preventive injection called nirsevimab (Beyfortus) helps protect infants from severe RSV. It is a monoclonal antibody that provides passive immunity for about 5 months.
Infants aged 6 months and under and children with high-risk conditions are prioritized.
Yes. HMG Pediatric offices in Kingsport, Bristol, and Abingdon offer RSV antibody protection for eligible infants and high-risk children.
Please contact your HMG Pediatric office for current availability or to schedule an appointment.